Form D · Biotechnology
Embody, Inc.
Vienna, VA · CIK 0001809164
Offering snapshot reported Oct 12, 2022 · SEC filing
- Reported sold
- $10.4M Offering amount: $12M
- Investors reported
- 94 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 23, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 12, 2022 | Initial | $10,425,481 | No comparison | 94 | SEC filing |
| Jul 19, 2021 | Initial | $10,532,494 | No comparison | Not reported | SEC filing |
| Apr 10, 2020 | Initial | $9,255,001 | No comparison | 50 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-461547
Source: Form D, filed Oct 12, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rob Ball | Director |
| Jeffrey Conroy | Director, Executive |
| Michael Francis | Director |
| Tim Meyers | Director |
| Michael O'kane | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2720 Willow Dr
Vienna, VA, 22181
Vienna, VA, 22181